Publication date: Available online 12 November 2026 Source: Journal of the American Academy of Dermatology Author(s): Hibo Rijal, Neda Shahriari, Marley Cutrona, Christopher G. Bunick, E.James Song, Peter Lio, Tina Bhutani-Jacques, Lindsay Ackerman, Jeffrey M. Cohen, Lisa Swanson, Mark C. Marchitto, Sam Awan, Diego Ruiz Dasilva, Clarissa Gomez, Sarah Berman, Tyler Chinyere, Alexandra K. Golant, Mona Shahriari
No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study. // Journal of the American Academy of Dermatology. – URL: https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all
No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study. Journal of the American Academy of Dermatology. https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all
“No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study.” Journal of the American Academy of Dermatology.
@article{article55707,
title = {No New Safety Signals With Ruxolitinib Cream Used in Combination With Systemic Therapies for Atopic Dermatitis: A Multicenter Retrospective Study},
journal = {Journal of the American Academy of Dermatology},
url = {https://www.sciencedirect.com/science/article/pii/S0190962226039174?dgcid=rss_sd_all}
}